Christine Cassetti, Italian, and virologist at Niaid, the Research Institute on Allergy and Infectious Diseases; led by Anthony Fauci is very optimistic.
Dr. Cassetti expresses herself with enthusiasm, since it had never happened to have important data on the effectiveness of a vaccine after just 10 months of experimentation.
Christine Cassetti
Doctor Cristina Cassetti is therefore unbalanced; deputy director of the "Microbiology and Infectious Disease" division of the Institute for Infectious Diseases, close collaborator of Dr. Maw. For Pfizer, that's a lot encouraging. The company has already reviewed the first data from phase three; that is to say the experimentation which involved about 40 thousand people. Meanwhile, other pharmaceutical companies are also on track to achieve excellent results soon. Despite this, Dr. Cassetti calls for caution, because the effect of the vaccine must also act on asymptomatic infections. However, at the moment they already are two vaccines against covid-19, perhaps authorized in the US, by December. For now, the data provided by Pfizer travels on the 90% overall effectiveness. However, many details still need to be filed out. Furthermore, we are also eagerly awaiting shortly; to be able to evaluate the relative data of the phase 3 trial of the "Modern". Equivalent results are hoped for from the pharmaceutical company.
